Intravenous administration of iron in epoetin-treated haemodialysis patients - which drugs, which regimen?

被引：33

作者：

Macdougall, IC ^{[1
]}

机构：

[1] Kings Coll Hosp London, Renal Unit, Dept Renal Med, London SE22 8PT, England

来源：

关键词：

D O I：

10.1093/ndt/15.11.1743

中图分类号：

R3 [基础医学]; R4 [临床医学];

学科分类号：

1001 ; 1002 ; 100602 ;

摘要：

[No abstract available]

引用

页码：1743 / 1745

页数：3

共 29 条

[1] [Anonymous], 1997, Am J Kidney Dis, V30, pS192
[2] Banyai Susanne, 1998, Journal of the American Society of Nephrology, V9, p198A
[3] European Best Practice Guidelines for renal transplantation (part 1) - Preface
Berthoux, F
[J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2000, 15 : 2 - 2
[4] Besarab A, 2000, J AM SOC NEPHROL, V11, P530, DOI 10.1681/ASN.V113530
[5] Collins A., 1998, Journal of the American Society of Nephrology, V9, p204A
[6] COLLINS A, 1997, J AM SOC NEPHROL, V8, P190
[7] Iron management in end-stage renal disease
Fishbane, S
Maesaka, JK
[J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 1997, 29 (03) : 319 - 333
[8] REDUCTION IN RECOMBINANT-HUMAN-ERYTHROPOIETIN DOSES BY THE USE OF CHRONIC INTRAVENOUS IRON SUPPLEMENTATION
FISHBANE, S
FREI, GL
MAESAKA, J
[J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 1995, 26 (01) : 41 - 46
[9] The safety of intravenous iron dextran in hemodialysis patients
Fishbane, S
Ungureanu, VD
Maesaka, JK
Kaupke, CJ
Lim, V
Wish, J
[J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 1996, 28 (04) : 529 - 534
[10] Anemia management of adult hemodialysis patients in the US: Results from the 1997 ESRD Core Indicators Project
Frankenfield, D
Johnson, CA
Wish, JB
Rocco, MV
Madore, F
Owen, WF
[J]. KIDNEY INTERNATIONAL, 2000, 57 (02) : 578 - 589